Results 121-140 of 8,606 for speaker:John Brady
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I get all of that. I am just looking for the specific numbers relating to the suspension of funding. How many patients have been referred over to the NTPF? With funding suspended, what is the real impact on patients in the context of their being in a vacuum? Do we have numbers in this regard?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Are their any cases of patients who had been referred to the NTPF and had a date for a procedure or whatever who are now back on an NTPF waiting list?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Were there no cases of direct negative impact on patients?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: That is fair enough. In relation to the cost of insourcing, Ms Brady referred to a split of 70-30. What was the exact figure for insourcing for 2024?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: For the record, what were the figures for insourcing and outsourcing at Beaumont in 2023?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: With regard to SIPO, which one of the members referred to earlier, there is a responsibility on consultants to fill in the relevant statutory declarations. A figure of 25% non-compliance was provided in that regard. There may be reasons for that. Ms Brady gave the example whereby when she was in Drogheda hospital, all consultants filled that in. Is that the case-----
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: -----irrespective of whether they had something to declare or-----
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: They filled it in. There was a process for all consultants to fill it in.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: It is mandatory.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: In the context of Beaumont, a figure of 81% was provided in respect of the public-only contract. How many consultants in total are engaged by Beaumont?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: But there is no process, similar to that in Drogheda, to ensure that the responsibility of the employer, which, in this case, is Beaumont, is complied with. There is no cross-referencing or anything like that to ensure that this is the case.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I think the management certainly does. There is work that needs to be done in that regard. I will deal with the issue of insourcing. Mr. Hanlon gave two figures for Beaumont for 2024, namely €11 million and €8.7 million. Will he explain why the figures are different?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: In 2024, it was €8.7 million.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Can Mr. Hanlon break that down further with regard to insourcing for third parties, particularly as there is a difference?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Okay.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: The €3.1 million was for insourcing. Would I be correct in saying that was to cover, I suppose, consultants who were on public contracts but it also involves engaging with third parties and utilising their work outside of and bringing them into Beaumont?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Will Ms Brady give us a breakdown of the figures relating to the insourcing and the engagement with third parties for 2024?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I will park my questions for now and will return to them if we get a second round.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: To return to the issue of in-sourcing, I refer to the report by the Minister that revealed that in the 27 months to the end of March 2025, close to €100 million was paid out engaging external companies that use HSE facilities and equipment after normal hours. The report revealed that 83 serving or former health staff are acting as directors in 148 companies providing what are known as...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Is that how Ms Coyle would see it in operation in Beaumont Hospital?